T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Amazon
AMZN
|
+$3.55B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.02B |
| 3 |
EQT Corp
EQT
|
+$1.52B |
| 4 |
Adobe
ADBE
|
+$1.29B |
| 5 |
Constellation Energy
CEG
|
+$1.16B |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.09B |
| 2 |
UnitedHealth
UNH
|
+$1.75B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.69B |
| 4 |
Ross Stores
ROST
|
+$1.64B |
| 5 |
ASML
ASML
|
+$1.59B |
Sector Composition
| 1 | Technology | 31.66% |
| 2 | Healthcare | 16.93% |
| 3 | Consumer Discretionary | 11.06% |
| 4 | Financials | 10.59% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NARI
576
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $79M | 0.01% |
1,359,337
-504,479
| -27% | -$29.3M |
|
577
Atkore
ATKR
$2.04B
| $79M | 0.01% |
506,322
-64,631
| -11% | -$10.1M |
|
578
Xencor
XNCR
$596M
| $78.9M | 0.01% |
3,158,576
-130,313
| -4% | -$3.25M |
|
579
Medpace
MEDP
$13.4B
| $78.1M | 0.01% |
325,116
-1,895
| -0.6% | -$455K |
|
580
Ecolab
ECL
$76.3B
| $78M | 0.01% |
418,025
-5,365
| -1% | -$1M |
|
581
Texas Roadhouse
TXRH
$11B
| $77.9M | 0.01% |
693,973
-4,254
| -0.6% | -$478K |
|
582
UFP Industries
UFPI
$5.84B
| $76.9M | 0.01% |
792,752
+24,597
| +3% | +$2.39M |
|
583
Edwards Lifesciences
EW
$46B
| $76.7M | 0.01% |
813,405
-18,108
| -2% | -$1.71M |
|
584
Shoals Technologies Group
SHLS
$1.15B
| $76.7M | 0.01% |
3,001,718
+231,302
| +8% | +$5.91M |
|
585
Zentalis Pharmaceuticals
ZNTL
$105M
| $75.7M | 0.01% |
2,684,352
+484,183
| +22% | +$13.7M |
|
586
West Fraser Timber
WFG
$5.84B
| $75.7M | 0.01% |
879,983
+183,346
| +26% | +$15.8M |
|
587
CDW
CDW
$22.4B
| $75.6M | 0.01% |
412,128
-21,012
| -5% | -$3.86M |
|
588
Murphy USA
MUSA
$7.26B
| $75.1M | 0.01% |
241,494
-2,093
| -0.9% | -$651K |
|
589
Iridium Communications
IRDM
$1.91B
| $74.6M | 0.01% |
1,200,538
+20,061
| +2% | +$1.25M |
|
590
Incyte
INCY
$16.8B
| $74.4M | 0.01% |
1,195,753
-622,594
| -34% | -$38.8M |
|
591
Sanofi
SNY
$115B
| $74.3M | 0.01% |
1,378,928
-664,489
| -33% | -$35.8M |
|
592
Avidity Biosciences
RNA
$5.97B
| $74.1M | 0.01% |
6,684,241
-180,144
| -3% | -$2M |
|
593
UiPath
PATH
$6.21B
| $73.8M | 0.01% |
4,452,706
+977,918
| +28% | +$16.2M |
|
594
Structure Therapeutics
GPCR
$1.2B
| $73.7M | 0.01% |
1,773,350
+986,845
| +125% | +$41M |
|
595
Ameriprise Financial
AMP
$46.4B
| $73.6M | 0.01% |
221,509
-95
| -0% | -$31.6K |
|
596
Watsco
WSO
$15.8B
| $73.4M | 0.01% |
192,397
-104
| -0.1% | -$39.7K |
|
597
Gaming and Leisure Properties
GLPI
$13.6B
| $73.3M | 0.01% |
1,511,934
+162,380
| +12% | +$7.87M |
|
598
Zai Lab
ZLAB
$3.16B
| $72.8M | 0.01% |
2,625,115
+215,742
| +9% | +$5.98M |
|
599
Albemarle
ALB
$8.63B
| $72.2M | 0.01% |
323,743
+83,718
| +35% | +$18.7M |
|
600
Doximity
DOCS
$12.9B
| $71.8M | 0.01% |
2,111,194
-241,542
| -10% | -$8.22M |
|